Menu
Montecito
PacPremier
Loading...
You are here:  Home  >  Central Coast Health Watch  >  Current Article

Repatha study shows cholesterol reduction for Type 2 diabetes patients

By   /   Monday, June 25th, 2018  /   Comments Off on Repatha study shows cholesterol reduction for Type 2 diabetes patients

    Print       Email
Amgen announced the release of new data from a phase 3 study June 23 that showed its cholesterol drug Repatha reduced two key types of cholesterol by more than 50 percent in patients with Type 2 diabetes. Presented at the American Diabetes Association annual meeting, the study – dubbed Banting by the Thousand Oaks biotech…

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

Henry Dubroff

Dubroff: U.S. Bank’s big buy revives long-simmering rivalry with Wells Fargo

Read More →